Status:
COMPLETED
Continous Monitoring of Vital Signs on Hospitalized Cancer Patients.
Lead Sponsor:
Naestved Hospital
Conditions:
Cancer
Fever
Eligibility:
All Genders
18+ years
Brief Summary
Clinical Data Validation of a Novel Continuous Vital Sign Monitoring System in Cancer Patients Background The Cortrium C3 device is a novel, inexpensive, chest-worn unit designed for measuring vital s...
Detailed Description
Clinical Data Validation of a Novel Continuous Vital Sign Monitoring System in Cancer Patients Background The Cortrium C3 device is a novel, inexpensive, chest-worn unit designed for measuring vital ...
Eligibility Criteria
Inclusion
- Hospitalized febrile cancer patient. Temperatur above 38,5 C -
- 18 years old or more
Exclusion
- Fertile women, not using birth control
- Pregnant women
- Inhabile patient, not able to understand information -
- Known heaert disease
Key Trial Info
Start Date :
February 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2018
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04299230
Start Date
February 1 2016
End Date
January 31 2018
Last Update
March 6 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Naestved Hospital
Næstved, Denmark, 4700
2
Næstved, Denmark, 4700